Ribosome biosynthetic and translation factor genes are pervasive targets of KAT2A (12, 33), and our data suggest that destabilization of translation acts to facilitate transformation at least transiently and down-regulation of translation-associated genes may accompany preleukemia to leukemia progression. The gene discussed is KAT2A; the disease is myelodysplastic syndrome.